866-997-4948(US-Canada Toll Free)

United States Irritable Bowel Syndrome with Constipation Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 115 Pages

Notes:
Sales, means the sales volume of Irritable Bowel Syndrome with Constipation Drugs
Revenue, means the sales value of Irritable Bowel Syndrome with Constipation Drugs

This report studies sales (consumption) of Irritable Bowel Syndrome with Constipation Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others
Split by applications, this report focuses on sales, market share and growth rate of Irritable Bowel Syndrome with Constipation Drugs in each application, can be divided into
Hospitals
Clinics
Others

Table of Contents

United States Irritable Bowel Syndrome with Constipation Drugs Market Report 2017
1 Irritable Bowel Syndrome with Constipation Drugs Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome with Constipation Drugs
1.2 Classification of Irritable Bowel Syndrome with Constipation Drugs
1.2.1 Lubiprostone
1.2.2 Linaclotide
1.2.3 Stimulant Laxatives
1.2.4 Osmotic Laxatives
1.2.5 Others
1.3 Application of Irritable Bowel Syndrome with Constipation Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Irritable Bowel Syndrome with Constipation Drugs (2012-2022)
1.4.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Growth Rate (2012-2022)

2 United States Irritable Bowel Syndrome with Constipation Drugs Competition by Manufacturers
2.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Irritable Bowel Syndrome with Constipation Drugs Average Price by Manufactures (2015 and 2016)
2.4 Irritable Bowel Syndrome with Constipation Drugs Market Competitive Situation and Trends
2.4.1 Irritable Bowel Syndrome with Constipation Drugs Market Concentration Rate
2.4.2 Irritable Bowel Syndrome with Constipation Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Irritable Bowel Syndrome with Constipation Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales and Market Share by States (2012-2017)
3.2 United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Irritable Bowel Syndrome with Constipation Drugs Price by States (2012-2017)

4 United States Irritable Bowel Syndrome with Constipation Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Irritable Bowel Syndrome with Constipation Drugs Price by Type (2012-2017)
4.4 United States Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate by Type (2012-2017)

5 United States Irritable Bowel Syndrome with Constipation Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Irritable Bowel Syndrome with Constipation Drugs Manufacturers Profiles/Analysis
6.1 Nestle
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.1.2.1 Lubiprostone
6.1.2.2 Linaclotide
6.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Abbot Laboratories
6.2.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.2.2.1 Lubiprostone
6.2.2.2 Linaclotide
6.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Synergy Pharmaceuticals
6.3.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.3.2.1 Lubiprostone
6.3.2.2 Linaclotide
6.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sucampo Pharmaceuticals
6.4.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.4.2.1 Lubiprostone
6.4.2.2 Linaclotide
6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.5.2.1 Lubiprostone
6.5.2.2 Linaclotide
6.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Astellas Pharmaceuticals
6.6.2 Irritable Bowel Syndrome with Constipation Drugs Product Type, Application and Specification
6.6.2.1 Lubiprostone
6.6.2.2 Linaclotide
6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview

7 Irritable Bowel Syndrome with Constipation Drugs Manufacturing Cost Analysis
7.1 Irritable Bowel Syndrome with Constipation Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Irritable Bowel Syndrome with Constipation Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Irritable Bowel Syndrome with Constipation Drugs Market Forecast (2017-2022)
11.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Type (2017-2022)
11.3 United States Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Application (2017-2022)
11.4 Irritable Bowel Syndrome with Constipation Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Irritable Bowel Syndrome with Constipation Drugs
Table Classification of Irritable Bowel Syndrome with Constipation Drugs
Figure United States Sales Market Share of Irritable Bowel Syndrome with Constipation Drugs by Type in 2015
Figure Lubiprostone Picture
Figure Linaclotide Picture
Figure Stimulant Laxatives Picture
Figure Osmotic Laxatives Picture
Figure Others Picture
Table Application of Irritable Bowel Syndrome with Constipation Drugs
Figure United States Sales Market Share of Irritable Bowel Syndrome with Constipation Drugs by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales and Growth Rate (2012-2022)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Growth Rate (2012-2022)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Irritable Bowel Syndrome with Constipation Drugs Sales Share by Manufacturers
Figure 2016 Irritable Bowel Syndrome with Constipation Drugs Sales Share by Manufacturers
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers
Table 2016 United States Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers
Table United States Market Irritable Bowel Syndrome with Constipation Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Irritable Bowel Syndrome with Constipation Drugs Average Price of Key Manufacturers in 2015
Figure Irritable Bowel Syndrome with Constipation Drugs Market Share of Top 3 Manufacturers
Figure Irritable Bowel Syndrome with Constipation Drugs Market Share of Top 5 Manufacturers
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales by States (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Share by States (2012-2017)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by States in 2015
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Market Share by States (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome with Constipation Drugs by States (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Price by States (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Share by Type (2012-2017)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2015
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Market Share by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome with Constipation Drugs by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Price by Type (2012-2017)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2012-2017)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2012-2017)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2015
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate by Application (2012-2017)
Table Nestle Basic Information List
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Nestle Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Abbot Laboratories Basic Information List
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Synergy Pharmaceuticals Basic Information List
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Sucampo Pharmaceuticals Basic Information List
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Astellas Pharmaceuticals Basic Information List
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Constipation Drugs
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs
Figure Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome with Constipation Drugs Major Manufacturers in 2015
Table Major Buyers of Irritable Bowel Syndrome with Constipation Drugs
Table Distributors/Traders List
Figure United States Irritable Bowel Syndrome with Constipation Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Irritable Bowel Syndrome with Constipation Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Irritable Bowel Syndrome with Constipation Drugs Production Forecast by Type (2017-2022)
Table United States Irritable Bowel Syndrome with Constipation Drugs Consumption Forecast by Application (2017-2022)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by States (2017-2022)
Table United States Irritable Bowel Syndrome with Constipation Drugs Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *